TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Dihydroartemisinin, Osimertinib
Phytochemical Name Dihydroartemisinin (PubChem CID: 3000518 )
Anticancer drug Name Osimertinib (PubChem CID: 71496458 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Reversing Drug Resistance
Hide/Show
Combination Pair ID: 164
Pair Name Dihydroartemisinin, Osimertinib
Disease Info [ICD-11: 2C25] Lung cancer Investigative
Biological Phenomena Induction-->ROS generation
Gene Regulation Down-regulation Expression HMOX1 hsa3162
Up-regulation Expression ROS1 hsa6098
In Vitro Model PC-9 Lung adenocarcinoma Homo sapiens (Human) CVCL_B260
PC-9/GR4 Lung adenocarcinoma Homo sapiens (Human) CVCL_DH34
In Vivo Model PC-9 or PC9-GR4-AZD1 cells (4×10⁶ cells resuspended in 200 μl of 1:1 mixture of PBS / Corning Matrigel Basement Membrane Matrix) were injected subcutaneously into the right flank of mice.
Result The results suggest that DHA is able to reverse the resistance to osimertinib in EGFR-mutant NSCLC by elevating ROS level and impair heme metabolism.
03. Reference
No. Title Href
1 Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer. Pharmacol Res. 2021 Aug;170:105701. doi: 10.1016/j.phrs.2021.105701. Click
It has been 27026 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP